← Evidence map

ArticleCell reports2022

Baricitinib attenuates the proinflammatory phase of COVID-19 driven by lung-infiltrating monocytes.

Brian Dobosh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

10 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35688145